Detection of the p110 β subunit of phosphatidylinositol 43-kinase complexed with neutral endopeptidase

Anticancer Research

Volumn 22, Issue 5, 2002, Pages 2533-2538

  Shen, Ruoqian ^a   Milowsky, Matthew I ^a   Ozaki, Naoko ^a   Navarro, Daniel ^a   Sumitomo, Makoto ^a   Xu, Yang ^b   Nanus, David M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b CIPHERGEN BIOSYSTEMS INC   (United States)

Author keywords

Neutral endopeptidase; P110 subunit; PI3 kinase; ProteinChip Array; SELDI TOF

Indexed keywords

CYTOPLASM PROTEIN; MEMBRANE METALLOENDOPEPTIDASE; MONOCLONAL ANTIBODY; NEUROPEPTIDE; PEPTIDASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE; PROTEIN; PROTEIN KINASE LYN; PROTEIN P110; PROTEIN P85; UNCLASSIFIED DRUG;

ARTICLE; BETA CHAIN; CATALYSIS; COMPLEX FORMATION; ENZYME SUBUNIT; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TECHNOLOGY; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BLOTTING, WESTERN; HUMANS; MALE; MASS SPECTROMETRY; MELANOMA; NEPRILYSIN; PRECIPITIN TESTS; PROSTATIC NEOPLASMS; PROTEIN ARRAY ANALYSIS; PROTEIN STRUCTURE, TERTIARY; TUMOR CELLS, CULTURED;

EID: 0036765805     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Aprikian AG, Han K, Guy L, Landry F, Begin LR and Chevalier S: Neuroendocrine differentiation and the bombesin/gastrin-releasing peptide family of neuropeptides in the progression of human prostate cancer. Prostate Suppl (8): 52-61, 1998.
2. Nelson JB and Carducci MA: Small bioactive peptides and cell surface peptidases in androgen-independent prostate cancer. Cancer Invest 18(1): 87-96, 2000.
3. Shipp MA, Tarr GE, Chen CY, Switzer SN, Hersh LB, Stein H, Sunday ME and Reinherz EL: CD10/neutral endopeptidase 24.11 hydrolyzes bombesin-like peptides and regulates the growth of small cell carcinomas of the lung. Proc Natl Acad Sci USA 88(23): 10662-10666, 1991.
4. Ganju RK, Sunday M, Tsarwhas DG, Card A and Shipp MA: CD10/NEP in non-small cell lung carcinomas. Relationship to cellular proliferation. J Clin Invest 94(5): 1784-1791, 1994.
5. Papandreou CN, Usmani B, Geng Y, Bogenrieder T, Freeman R, Wilk S, Finstad CL, Reuter VE, Powell CT, Scheinberg D, Magill C, Scher HI, Albino AP and Nanus DM: Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression. Nat Med 4(1): 50-57, 1998.
6. Dai J, Shen R, Sumitomo M, Goldberg JS, Geng Y, Navarro D, Xu S, Koutcher JA, Garzotto M, Powell CT and Nanus DM: Tumor-suppressive effects of neutral endopeptidase in androgen-independent prostate cancer cells. Clin Cancer Res 7(5): 1370-1377, 2001.
7. Sumitomo M, Shen R, Walburg M, Dai J, Geng Y, Navarro D, Boileau G, Papandreou CN, Giancotti FG, Knudsen B and Nanus DM: Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling. J Clin Invest 106(11): 1399-1407, 2000.
8. Vanhaesebroeck B and Waterfield MD: Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res 253(1): 239-254, 1999.
9. Kuwata H, Yip TT, Yip CL, Tomita M and Hutchens TW: Bactericidal domain of lactoferin: detection quantitation, and characterization of lactoferricin in serum by seldi affinity mass spectrometry. Biochem Biophy Res Com 245: 764-773, 1998.
10. Wright Jr GL, Cazares LH, Leung SM, Nasim S, Adam BL, Yip TT, Schelhammer PF, Gong L and Vlahou A: Proteinchip surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate Cancer and Prostatic Diseases 2: 264-276, 1999.
11. Hampel DJ, Sansome C, Sha M, Brodsky S, Lawson W and Goligorsky S: Toward proteomics in uroscopy: urinary protein profiles after radiocontrast medium administration. J AM Soc Nephrol 12: 1026-1035, 2001.
12. Petricoln III EF, Ardekanl AM, Hitt BA, Levine PJ, Vincent AF, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC and Liotta LA: Use of proteomic patterns in serum to identify ovarian cancer. Mechanism of Disease 359: 572-577, 2002.
13. Ganju RK, Shpektor RG, Brenner DG and Shipp MA: CD10/neutral endopeptidase 24.11 is phosphorylated by casein kinase II and coassociates with other phosphoproteins including the lyn src-related kinase. Blood 88(11): 4159-4165, 1996.
14. Hu P, Mondino A, Skolnik EY and Schlessinger J: Cloning of a novel ubiquitously expressed human phosphatidylinositol 3-kinase and identification of its binding site on p85. Mol Cell Biol 13(12): 7677-7688, 1993.
15. Rodriguez VP, Warne PH, Dhand R, Vanhaesebroeck B, Gout I, Fry MJ, Waterfield MD and Downward J: Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370: 527-532, 1994.
16. Schafer U, Seibold S, Schneider A and Neugebauer E: Isolation and characterization of the human rab 18 gene after stimulation of endothelial cells with histamine. FEBS letters 466: 148-154, 2000.
17. Hooshmand-Rad R, Hajkova L, Klint P, Karlsson R, Vanhaesebroeck B, Claesson-Welsh L and Heldin CH: The PI 3-kinase isoforms p110(alpha) and p110(beta) have differential roles in PDGF- and insulin-mediated signaling. J Cell Sci 113 Pt 2: 207-214, 2000.
18. Roche S, Koegl M and Courtneidge SA: The phosphatidylinositol 3-kinase alpha is required for DNA synthesis induced by some, but not all, growth factors. Proc Natl Acad Sci USA 91(19): 9185-9189, 1994.
19. Roche S, Downward J, Raynal P and Courtneidge SA: A function for phosphatidylinositol 3-kinase beta (p85alpha-p110beta) in fibroblasts during mitogenesis: requirement for insulin- and lysophosphatidic acid-mediated signal transduction. Mol Cell Biol 12(7): 119-129, 1998.
20. Deora AA, Win T, Vanhaesebroeck B, Lander A: A redox-triggered ras-effector interaction. Recruitment of phosphatidylinositol 3′-kinase to Ras by redox stress. J Biol Chem 273(45): 29923-29928, 1998.